+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Miconazole nitrate vaginal suppository 1,200 mg versus oral fluconazole 150 mg in treating severe vulvovaginal candidiasis



Miconazole nitrate vaginal suppository 1,200 mg versus oral fluconazole 150 mg in treating severe vulvovaginal candidiasis



Gynecologic and Obstetric Investigation 80(2): 113-118



Miconazole is a synthetic imidazole antifungal that has a broad spectrum of activity against Candida albicans and non-albicans Candida species. The aim of this study was to evaluate the efficacy and safety of miconazole nitrate vaginal suppository and oral fluconazole in treating severe vulvovaginal candidiasis (SVVC). In this prospective, randomized case control study, 577 cases of consecutive patients with SVVC were studied at the Gynecological Clinic of Peking University Shenzhen Hospital from January 1, 2009 through December 31, 2010. Patients with SVVC were treated with two doses of miconazole nitrate vaginal suppository 1,200 mg or two doses of fluconazole 150 mg. The patients were followed up for 7-14 and 30-35 days following the second dose of therapy. The mycological cure rates of the patients on days 7-14 of follow-up were 75.9% (220/290) and 84.0% (241/287) in the miconazole and fluconazole groups, respectively (p < 0.05). The mycological cure rates of the patients at the second follow-up were 64.8% (188/290) and 69.7% (200/287), respectively, in the two groups (p > 0.05). The study demonstrated that two doses of miconazole nitrate vaginal suppository 1,200 mg were as effective as two doses of an oral fluconazole 150 mg regimen in the treatment of patients with SVVC.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058307533

Download citation: RISBibTeXText

PMID: 25720546

DOI: 10.1159/000371759


Related references

A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis. Medical Mycology 53(5): 455-461, 2016

The efficacy and safety of clotrimazole vaginal tablet vs. oral fluconazole in treating severe vulvovaginal candidiasis. Mycoses 59(7): 419-428, 2017

Single-dose miconazole nitrate vaginal ovule in the treatment of vulvovaginal candidiasis: two single-blind, controlled studies versus miconazole nitrate 100 mg cream for 7 days. Journal of Women's Health and Gender-Based Medicine 9(4): 421-429, 2000

Safety and efficacy of bedtime versus daytime administration of the miconazole nitrate 1200 mg vaginal ovule insert to treat vulvovaginal candidiasis. Current Medical Research and Opinion 21(1): 127-134, 2005

Safety and efficacy of bedtime versus daytime administration of the miconazole nitrate 1200mg vaginal ovule insert to treat vulvovaginal candidiasis. Current Medical Research and Opinion 21(1): 127-134, 2005

Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis. Mycopathologia 179(1-2): 95-101, 2016

Observation of the effect of fluconazole combined with miconazole nitrate on vulvovaginal candidiasis. 2007

Long term vaginal azoles versus prophylactic oral fluconazole in treatment of Recurrent Vulvovaginal Candidiasis. 2007

Oral fluconazole 150 mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis. Journal of Infection and Public Health 4(4): 195-199, 2012

Cure rates of oral contraceptive users and non-users when treated for vulvovaginal candidiasis (moniliasis) with miconazole nitrate 2% vaginal cream. Contraception 15(3): 355-361, 1977

Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate. Official Gazette of the United States Patent & Trademark Office Patents 1240(4), Nov 28, 2000

Oral fluconazole 15mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis. 2011

Butoconazole nitrate 2% for vulvovaginal candidiasis. New, single-dose vaginal cream formulation vs. seven-day treatment with miconazole nitrate. Gynazole 1 Study Group. Journal of Reproductive Medicine 44(11): 933-938, 1999

Effect of butoconazole nitrate 2% vaginal cream and miconazole nitrate 2% vaginal cream treatments in patients with vulvovaginal candidiasis. Infectious Diseases in Obstetrics and Gynecology 4(6): 323-328, 1996

Clinical effect and safety of miconazole nitrate 1200 mg in treating vulvovaginal candidiasis. Zhonghua Fu Chan Ke Za Zhi 43(10): 757-759, 2011